نتایج جستجو برای: 50 superior companies

تعداد نتایج: 668936  

Journal: :Tropical medicine & international health : TM & IH 2001
C Pérez-Casas E Herranz N Ford

Effective medicines exist to treat or alleviate many diseases which predominate in the developing world and cause high mortality and morbidity rates. Price should not be an obstacle preventing access to these medicines. Increasingly, drug donations have been established by drug companies, but these are often limited in time, place or use. Measures exist which are more sustainable and will have ...

2003
Matthias Meitner

Classical single-factor comparable company valuation (CCV) like e.g. valuation using the price-earnings ratio is associated with several shortcomings. The two most important are the non-applicability of negative values in the basis of reference and the high requirements to the qualitative characteristics of comparable companies. This paper develops a multi-factor CCV model based on substance an...

Journal: :WMJ : official publication of the State Medical Society of Wisconsin 2010
Cody Soyk Branden Pfefferkorn Patrick McBride Richard Rieselbach

PURPOSE Medical students are at-risk to the influence of pharmaceutical company (Pharma) marketing. As interactions with the industry come under increasing scrutiny and regulation, previous studies on student-Pharma relations no longer may be accurate. This study assessed students' attitudes toward and interactions with Pharmas at the University of Wisconsin School of Medicine and Public Health...

2008
Ramin Rajabioun Ashkan Rahimi-Kian

In this paper, first a precise mathematical model is obtained for four competing or cooperating companies’ stock prices and then the optimal buy/sell signals are ascertained for five different agents which are trading in a virtual market and are trying to maximize their wealth over 1 trading year period. The model is so that gives a good prediction of the next 30th day stock prices. The compani...

2005
Mats Williander

Whether or not it pays to be green or under what circumstances is an important ongoing debate among economic researchers. However, this question, with its rather instrumental rationality, may underestimate another key issue: the ability of companies to create value that can be captured from customers. This paper reports on three companies in the automotive industry developing and launching cars...

Fundamental and technical analyses are two common methods for predicting the future behavior of the stock. Fundamental analysis focuses on the economic forces of supply and demand which cause stock prices change. On the other hand, technical analysis examines historical data relating to changes in the price and trading volume by using graphs and indicators as a primary tool to predict future pr...

Journal: :Computers & OR 2011
Andreas T. Ernst Elena O. Gavriliouk Leorey Marquez

In this article we present a heuristic based on Lagrangean relaxation for scheduling rental vehicles. The scheduling problem can be formulated as a set of large assignment problems with linking constraints. We discuss the theory behind the heuristic, including the ability to obtain lower bounds. The heuristic is based on ideas first introduced by D. Wedelin. Empirical testing shows that our heu...

2001
Matti Tuominen Arto Rajala Kristian Möller

Globalization, acute competition, the information technology revolution, and increasing customer sophistication are radically redefining environmental conditions, and, meanwhile, challenging managerial representations and traditional organizational recipes for managing intraand inter-firm relationships. Hence, we examine in this study the way companies interact with their employees and customer...

2000
Miguel A. Rodríguez Joan E. Ricart

The purpose of this research paper is to show that the environmental variable influences companies’ value creation processes. The goal of any strategy is to achieve sustained superior performance, and this depends on the industry’s attractiveness and the choice of business positioning. In turn, the success of any given positioning depends on the sustainability of the competitive advantages on w...

2011
D Sreedhar MD Janodia VS Ligade

healthcare and Ranbaxy have been bought by Abbott and Daiichi Sankyo, respectively.[3] Cipla, an indigenous company, lone with a market share of about 5.4% tops the list of top 10 companies in India. The increasing presence of foreign companies among the top pharmaceutical companies in India is may be due to a few buyouts which happened in the recent past. Daiichi Sankyo, a leading Japanese pha...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید